Analysts 10 incl. previous ratings
Rating Distribution 6 Buy · 4 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Jan 30, 2026 Upgrade B Barclays
Equal Weight → Overweight $210 -19.9% Aug 25, 2025 Downgrade R Robert W. Baird
Outperform → Neutral $194 -26.0% Apr 02, 2025 Initiated R Redburn Atlantic
Buy $195 -25.6% Mar 04, 2025 Downgrade C Citigroup
Buy → Neutral $185 -29.4% Jan 06, 2025 Upgrade L Leerink Partners
Market Perform → Outperform $169 → $174 -33.6% Dec 17, 2024 Upgrade M Morgan Stanley
Equal-Weight → Overweight $145 → $172 -34.4% Dec 10, 2024 Resumed J Jefferies
Buy $175 → $185 -29.4% Oct 23, 2024 Upgrade R Robert W. Baird
Neutral → Outperform $157 → $182 -30.6% Aug 28, 2024 Resumed E Evercore ISI
In-line $165 -37.1% Jul 10, 2024 Upgrade C Citigroup
Neutral → Buy $145 → $165 -37.1% Feb 26, 2024 Initiated L Leerink Partners
Market Perform $135 -48.5% Feb 07, 2024 Upgrade J Jefferies
Hold → Buy $140 → $155 -40.9% Jan 03, 2024 Initiated B Barclays
Equal Weight $145 -44.7% Dec 12, 2023 Upgrade B BofA Securities
Neutral → Buy $140 → $160 -39.0% Jun 29, 2023 Initiated P Piper Sandler
Neutral May 02, 2023 Downgrade B BofA Securities
Buy → Neutral $166 → $148 -43.6% Apr 03, 2023 Upgrade C Citigroup
Sell → Neutral $125 → $142 -45.8% Jan 23, 2023 Initiated E Evercore ISI
In-line $159 -39.4% Nov 17, 2022 Downgrade C Citigroup
Neutral → Sell $145 → $125 -52.3% Aug 22, 2022 Resumed M Morgan Stanley
Equal-Weight $142 -45.8%
Show Previous Ratings
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Plewman Patrick SVP for Diagnostic Services Nov 09 '26 Option Exercise 127.77 11,067 1,414,076 22,127 Nov 12 07:13 PM Plewman Patrick SVP for Diagnostic Services Nov 09 '26 Sale 257.34 11,717 3,015,253 14,684 Nov 12 07:13 PM Plewman Patrick Officer Nov 09 '26 Proposed Sale 257.34 11,717 3,015,253 Nov 09 10:11 AM Doherty Catherine T. Executive Vice President Nov 03 '26 Option Exercise 121.81 22,105 2,692,500 94,054 Nov 05 07:05 PM Doherty Catherine T. Executive Vice President Nov 03 '26 Sale 248.02 22,105 5,482,442 71,949 Nov 05 07:05 PM Doherty Catherine T. Officer Nov 03 '26 Proposed Sale 252.64 22,105 5,584,607 Nov 03 10:10 AM PFEIFFER GARY M Director Oct 26 '26 Sale 243.00 1,203 292,329 29,802 Oct 28 06:05 PM PFEIFFER GARY M Director Oct 26 '26 Proposed Sale 243.00 1,203 292,329 Oct 26 09:46 AM Davis J. E. CEO and President Sep 01 '26 Sale 242.72 10,000 2,427,200 122,423 Sep 03 05:05 PM Davis J. E. Officer Sep 01 '26 Proposed Sale 242.72 10,000 2,427,200 Sep 01 11:06 AM PREVOZNIK MICHAEL E SVP & General Counsel Aug 28 '26 Option Exercise 112.17 22,677 2,543,679 60,234 Aug 31 04:37 PM PREVOZNIK MICHAEL E SVP & General Counsel Aug 28 '26 Sale 243.11 22,677 5,513,083 37,557 Aug 31 04:37 PM PREVOZNIK MICHAEL E Officer Aug 28 '26 Proposed Sale 243.11 22,677 5,513,082 Aug 28 04:08 PM DELANEY MARK E SVP & Chief Commercial Officer Jul 28 '26 Sale 235.18 1,600 376,288 10,335 Jul 29 05:04 PM DELANEY MARK E Officer Jul 28 '26 Proposed Sale 235.18 1,600 376,288 Jul 28 09:46 AM KUPPUSAMY KARTHIK SVP, Clinical Solutions Jun 04 '26 Option Exercise 124.22 8,147 1,012,000 21,657 Jun 08 04:32 PM KUPPUSAMY KARTHIK SVP, Clinical Solutions Jun 04 '26 Sale 200.00 8,147 1,629,400 13,510 Jun 08 04:32 PM KUPPUSAMY KARTHIK Officer Jun 04 '26 Proposed Sale 200.00 8,147 1,629,400 Jun 04 02:52 PM Davis J. E. CEO and President Jun 01 '26 Sale 194.14 10,000 1,941,400 132,423 Jun 02 06:38 PM Davis J. E. Officer Jun 01 '26 Proposed Sale 194.14 10,000 1,941,360 Jun 01 12:26 PM Doherty Catherine T. EVP, Regional Businesses Mar 05 '26 Sale 206.21 5,558 1,146,115 67,122 Mar 06 04:45 PM PREVOZNIK MICHAEL E SVP & General Counsel Mar 05 '26 Sale 206.21 3,878 799,682 37,557 Mar 06 04:44 PM Plewman Patrick SVP for Diagnostic Services Mar 05 '26 Sale 206.21 2,855 588,730 15,198 Mar 06 04:44 PM KUPPUSAMY KARTHIK SVP, Clinical Solutions Mar 04 '26 Sale 204.86 2,628 538,372 13,441 Mar 06 04:43 PM PREVOZNIK MICHAEL E Officer Mar 05 '26 Proposed Sale 206.21 3,878 799,682 Mar 05 11:53 AM Doherty Catherine T. Officer Mar 05 '26 Proposed Sale 206.21 5,558 1,146,115 Mar 05 10:55 AM Plewman Patrick Officer Mar 05 '26 Proposed Sale 206.21 2,855 588,730 Mar 05 10:43 AM Doherty Catherine T. EVP, Regional Businesses Mar 03 '26 Sale 207.73 632 131,285 67,122 Mar 04 04:39 PM PREVOZNIK MICHAEL E SVP & General Counsel Mar 03 '26 Sale 207.73 526 109,266 37,557 Mar 04 04:38 PM Davis J. E. CEO and President Mar 02 '26 Sale 212.52 10,000 2,125,200 117,185 Mar 04 04:38 PM Plewman Patrick SVP for Diagnostic Services Mar 03 '26 Sale 207.73 410 85,169 15,198 Mar 04 04:38 PM Doherty Catherine T. Officer Mar 03 '26 Proposed Sale 207.73 632 131,285 Mar 03 12:53 PM PREVOZNIK MICHAEL E Officer Mar 03 '26 Proposed Sale 207.73 526 109,266 Mar 03 12:12 PM Plewman Patrick Officer Mar 03 '26 Proposed Sale 207.73 410 85,169 Mar 03 11:52 AM Davis J. E. Officer Mar 02 '26 Proposed Sale 212.52 10,000 2,125,200 Mar 02 02:21 PM Plewman Patrick SVP for Diagnostic Services Feb 19 '26 Sale 204.83 958 196,227 15,838 Feb 20 05:13 PM PREVOZNIK MICHAEL E SVP & General Counsel Feb 19 '26 Sale 204.83 1,111 227,566 38,371 Feb 20 05:12 PM Doherty Catherine T. EVP, Regional Businesses Feb 19 '26 Sale 204.83 1,433 293,521 68,402 Feb 20 05:11 PM Plewman Patrick Officer Feb 19 '26 Proposed Sale 204.83 958 196,227 Feb 19 10:34 AM Doherty Catherine T. Officer Feb 19 '26 Proposed Sale 204.83 1,433 293,521 Feb 19 10:23 AM PREVOZNIK MICHAEL E Officer Feb 19 '26 Proposed Sale 204.83 1,111 227,566 Feb 19 10:19 AM Doherty Catherine T. EVP, Regional Businesses Feb 13 '26 Option Exercise 112.17 26,165 2,934,928 94,233 Feb 17 04:37 PM Doherty Catherine T. EVP, Regional Businesses Feb 13 '26 Sale 206.15 26,165 5,393,815 68,068 Feb 17 04:37 PM Doherty Catherine T. Officer Feb 13 '26 Proposed Sale 207.48 26,165 5,428,714 Feb 13 10:42 AM Plewman Patrick SVP for Diagnostic Services Feb 10 '26 Option Exercise 121.81 5,662 689,660 21,043 Feb 12 04:33 PM Plewman Patrick SVP for Diagnostic Services Feb 10 '26 Sale 204.00 5,662 1,155,048 15,381 Feb 12 04:33 PM Plewman Patrick Officer Feb 10 '26 Proposed Sale 204.00 5,662 1,155,048 Feb 10 12:46 PM Davis J. E. CEO and President Nov 25 '25 Option Exercise 95.80 55,093 5,277,634 175,573 Nov 28 04:30 PM Davis J. E. CEO and President Nov 25 '25 Sale 192.22 55,093 10,589,760 120,480 Nov 28 04:30 PM Gregg Vicky B Director Nov 25 '25 Sale 191.76 1,250 239,700 17,037 Nov 28 04:30 PM Davis J. E. Officer Nov 25 '25 Proposed Sale 192.22 55,093 10,589,762 Nov 25 04:24 PM Gregg Vicky B Director Nov 25 '25 Proposed Sale 191.76 1,250 239,700 Nov 25 09:42 AM DELANEY MARK E SVP & Chief Commercial Officer Nov 18 '25 Option Exercise 144.46 7,946 1,147,845 15,476 Nov 20 04:28 PM DELANEY MARK E SVP & Chief Commercial Officer Nov 18 '25 Sale 187.35 7,946 1,488,683 7,530 Nov 20 04:28 PM DELANEY MARK E Officer Nov 18 '25 Proposed Sale 187.35 7,946 1,488,683 Nov 18 11:02 AM